{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:34:29Z","timestamp":1787740469421,"version":"build-2784847793"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The global rise of multidrug-resistant (MDR) and extended-spectrum \u03b2-lactamase\u2013producing (ESBL)\n                      <jats:italic>Salmonella<\/jats:italic>\n                      undermines treatment efficacy and threatens public health, particularly in low-resource settings. In Nigeria, data on resistance mechanisms in clinical isolates remain sparse. This study evaluates whether resistance genes and antibiogram profiles can reliably predict MDR and ESBL phenotypes to enhance early detection and surveillance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This cross-sectional, laboratory-based study was conducted from January-December 2024 and analyzed 265 clinical samples (241 faecal, 24 blood) from patients with suspected enteric fever at a Nigerian tertiary hospital. Sixty-five\n                      <jats:italic>Salmonella<\/jats:italic>\n                      isolates were identified via convenience sampling using standard microbiological methods and tested for antibiotic susceptibility using the Kirby\u2013Bauer disk diffusion method, per CLSI guidelines. ESBL production was screened by Double Disc Synergy Test, and PCR assays were performed to detect\n                      <jats:italic>blaTEM<\/jats:italic>\n                      ,\n                      <jats:italic>blaSHV, tetA<\/jats:italic>\n                      ,\n                      <jats:italic>qnrA\/B<\/jats:italic>\n                      , and\n                      <jats:italic>sul1<\/jats:italic>\n                      genes. MDR was defined as resistance to\u2009\u2265\u20093 antibiotic classes. Statistical analyses included chi-square tests, logistic regression (\u03b1\u2009=\u20090.05), and machine learning models: Classification and Regression Trees (CART), and Random Forest. SHAP (Shapley Additive Explanations) was used for interpretability.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Salmonella was isolated in 65 of 265 samples (26.9%), all from fecal specimens. Resistance was highest to amoxicillin\/clavulanic acid (98.5%), tetracycline (96.9%), and sulfamethoxazole\/trimethoprim (90.8%) while imipenem and polymyxin B remained effective with 96.9% and 95.4% susceptibility rate respectively. ESBL production was confirmed in 18 isolates (27.7%), while 28 (43.1%) met MDR criteria. The MDR rate was 89.2%, with a mean multiple antibiotic resistance index (MARI) of 0.52.\n                      <jats:italic>BlaTEM<\/jats:italic>\n                      (77.8%),\n                      <jats:italic>tetA<\/jats:italic>\n                      (72.2%), and\n                      <jats:italic>sul1<\/jats:italic>\n                      (61.1%) were the most prevalent resistance genes. ESBL status was strongly associated with MDR (aOR:4.6; 95%CI:1.5\u201314.3;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01). CTX resistance,\n                      <jats:italic>blaTEM<\/jats:italic>\n                      ,\n                      <jats:italic>tetA<\/jats:italic>\n                      , and\n                      <jats:italic>sul1<\/jats:italic>\n                      demonstrated the strongest predictive power for MDR, with respective AUCs of 0.91, 0.88, 0.82, and 0.78. These markers consistently ranked highest across multiple predictive modelling approaches, with SHAP analysis confirming their dominant contribution to MDR classification.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Resistance genes and antibiogram markers\u2014particularly\n                      <jats:italic>blaTEM<\/jats:italic>\n                      and CTX resistance\u2014predict MDR and ESBL status reliably. Leveraging these markers through machine learning\u2014combined with SHAP-based interpretability\u2014enables early, accurate detection and supports targeted antimicrobial interventions in resource-limited settings.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-12180-y","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T05:55:25Z","timestamp":1764309325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antibiotic susceptibility patterns of clinical isolates of salmonella species producing extended spectrum beta lactamases as predictor of multidrug resistance in a tertiary hospital, Southeastern Nigeria"],"prefix":"10.1186","volume":"25","author":[{"given":"Ugonna Cassandra","family":"Aniokete","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Uzor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henshaw Uchechi","family":"Okoroiwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam Chidi","family":"Ibeneme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifeanyichukwu Romanus","family":"Iroha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"12180_CR1","unstructured":"World Health Organization. Salmonella (Non-Typhoidal). Retrieved from 2018. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/salmonella-(non-typhoidal)."},{"issue":"6","key":"12180_CR2","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1086\/650733","volume":"50","author":"SE Majowicz","year":"2010","unstructured":"Majowicz SE, Musto J, Scallan E, Angulo FJ, Kirk M, O\u2019Brien SJ, Jones TF, Fazil A, Hoekstra RM International Collaboration on Enteric Disease \u2018Burden of Illness\u2019 Studies. The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis. 2010;50(6):882\u201389. https:\/\/doi.org\/10.1086\/650733.","journal-title":"Clin Infect Dis"},{"key":"12180_CR3","volume-title":"Typhoid","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. Typhoid. WHO; 2019. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/typhoid."},{"key":"12180_CR4","unstructured":"World Health Organization. Department of immunization, vaccines and biologicals (IVB). Presented at SAGE Meeting. Geneva, Switzerland: 2022 April 4\u20137. https:\/\/terrance.who.int\/mediacentre\/org."},{"key":"12180_CR5","unstructured":"World Health Organization. What is the difference between antibiotic and antimicrobial resistance? 2023. https:\/\/www.emro.who.int\/health-topics\/drug-resistance\/what-is-the-difference-between-antibiotic-and-antimicrobial-resistance.html."},{"issue":"5","key":"12180_CR6","first-page":"294","volume":"10","author":"R Ranjbar","year":"2018","unstructured":"Ranjbar R, Ardashiri M, Samadi S, Afshar D. Distribution of extended spectrum \u03b2-lactamases (ESBLs) among salmonella serogroups isolated from pediatric patients. Iran J Microbiol. 2018;10(5):294\u201399. PMCID: PMC6340002 PMID: 30675325.","journal-title":"Iran J Microbiol"},{"issue":"7","key":"12180_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.5897\/AJPP2020.5115","volume":"14","author":"NE Onyenwe","year":"2020","unstructured":"Onyenwe NE, Nnamani ND, Okoro JC, Nwofor CN, Jesumirhewe C. Prevalence and gene sequencing of extended spectrum \u03b2-lactamases producing Salmonella enterica serovar typhi from Southeast Nigeria. Afr J Pharm Pharmacol. 2020;14(7):192\u2013202. https:\/\/doi.org\/10.5897\/AJPP2020.5115.","journal-title":"Afr J Pharm Pharmacol"},{"issue":"9","key":"12180_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.9734\/jamps\/2023\/v25i9639","volume":"25","author":"UO Nwosu","year":"2023","unstructured":"Nwosu UO, Ibiam FA, Amadi-Ibiam CO, Aniokete UC, Iroha CS, Peter IU, Iroha IR. Antimicrobial resistance profile of Salmonella enterica serovar Typhi isolated from human clinical samples in Ebonyi State, Nigeria. J Adv Med Pharm Sci. 2023;25(9):11\u201317. https:\/\/doi.org\/10.9734\/jamps\/2023\/v25i9639.","journal-title":"J Adv Med Pharm Sci"},{"key":"12180_CR9","doi-asserted-by":"publisher","unstructured":"Uwanibe JN, Kayode TA, Oluniyi PE, Akano K, Olawoye IB, Ugwu CA, Happi CT, Folarin OA. The prevalence of undiagnosed Salmonella enterica serovar typhi in healthy school-aged children in Osun State, Nigeria. Pathogens. 2023;12(4):594. https:\/\/doi.org\/10.3390\/pathogens12040594.","DOI":"10.3390\/pathogens12040594"},{"issue":"1","key":"12180_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1080\/23144599.2024.2365567","volume":"12","author":"OS Abdullahi","year":"2024","unstructured":"Abdullahi OS, Abdurrahman HJ, Olubunmi GF, Oluwawemimo OA, Alexander RJ, Aminu S, \u2026 & Folorunso OF. Non-typhoidal Salmonella in Nigeria: do outcomes of multisectoral surveillance, treatment and control justify the intervention costs? Int J Vet Sci Med. 2024;12(1):48\u201359. https:\/\/doi.org\/10.1080\/23144599.2024.2365567.","journal-title":"Int J Vet Sci Med"},{"issue":"3","key":"12180_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.24875\/RIC.22000078","volume":"74","author":"KO Akinyemi","year":"2002","unstructured":"Akinyemi KO, Al-Khafaji NSK, Al-Alaq FT, Fakorede CO, Al-Dahmoshi HOM, Iwolokun BA, Akpabio I, Alkafaas SS, Saki M. Extended-spectrum beta-lactamase encoding genes among Salmonella enterica serovar typhi isolates in patients with typhoid fever from four academic medical centers in Lagos, Nigeria. Revista de Investigaci\u00f3n Cl\u00ednica. 2002;74(3):165\u201371. https:\/\/doi.org\/10.24875\/RIC.22000078.","journal-title":"Revista de Investigaci\u00f3n Cl\u00ednica"},{"issue":"9","key":"12180_CR12","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1128\/AAC.00913-13","volume":"57","author":"M DiMarzio","year":"2013","unstructured":"DiMarzio M, Shariat N, Kariyawasam S, Barrangou R, Dudley EG. Antibiotic resistance in Salmonella enterica serovar typhimurium associated with CRISPR sequence type. Antimicrob Agents Chemother. 2013;57(9):4282\u201389. https:\/\/doi.org\/10.1128\/AAC.00913-13.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"12180_CR13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.5455\/javar","volume":"3","author":"I Ifeanyichukwu","year":"2016","unstructured":"Ifeanyichukwu I, Chika E, Ogonna A, Chidinma I, Monique A, Ikechukwu M, Stanley E, Emmanuel N, Ngozi A, Agabus CN. Prevalence and antibiogram of salmonella species isolated from poultry products. J Adv Vet Anim Res. 2016;3(4):353\u201359. https:\/\/doi.org\/10.5455\/javar. 2016.c172.","journal-title":"J Adv Vet Anim Res"},{"issue":"6","key":"12180_CR14","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.jinf.2020.10.030","volume":"81","author":"CS Marchello","year":"2020","unstructured":"Marchello CS, Birkhold M, Crump JA. Complications and mortality of typhoid fever: a global systematic review and meta-analysis. The J Infect. 2020;81(6):902\u201310. https:\/\/doi.org\/10.1016\/j.jinf.2020.10.030.","journal-title":"The J Infect"},{"key":"12180_CR15","doi-asserted-by":"crossref","unstructured":"Iroha IR, Adikwu MU, Amadi ES, Aibinu I, Esimone CO. Characterization of extended spectrum \u03b2-lactamase producing E. coli from secondary and tertiary hospitals in southeastern Nigeria. researchj Microbiol. 2008;3:514\u201319. https:\/\/scialert.net\/abstract\/?doi=jm.2008.514.519.","DOI":"10.3923\/jm.2008.514.519"},{"key":"12180_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4236\/ajmb.2020.103014","volume":"10","author":"BO Okpa","year":"2020","unstructured":"Okpa BO, Gberikon GM, Aguora CU, Ogbonna IO. ESBL production and multidrug resistance of Salmonella serovars isolated in benue state. Am J Mol Biol. 2020;10:3. https:\/\/doi.org\/10.4236\/ajmb.2020.103014.","journal-title":"Am J Mol Biol"},{"key":"12180_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4172\/2476-213X.1000107","volume":"1","author":"O Oghenevo","year":"2016","unstructured":"Oghenevo O, Bassey B, Yhiler N, Francis U, Angela O. Antibiotic resistance in extended spectrum beta-lactamase (ESBL) Salmonella species isolated from patients with diarrhoea in Calabar, Nigeria. J Educ Chang Clin Infect Dis And Pract. 2016;1:107. https:\/\/doi.org\/10.4172\/2476-213X.1000107.","journal-title":"J Educ Chang Clin Infect Dis And Pract"},{"issue":"1","key":"12180_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/jac\/dki190","volume":"56","author":"H Hasman","year":"2005","unstructured":"Hasman H, Mevius D, Veldman K, Olesen I, Aarestrup FM. \u03b2-lactamases among extended-spectrum \u03b2-lactamase (ESBL)-resistant Salmonella from poultry products and human patients in the Netherlands. The J Antimicrob Chemother. 2005;56(1):115\u201321. https:\/\/doi.org\/10.1093\/jac\/dki190.","journal-title":"The J Antimicrob Chemother"},{"issue":"2","key":"12180_CR19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1128\/MMBR.00056-13","volume":"78","author":"MR Gillings","year":"2014","unstructured":"Gillings MR. Integrons: past, present, and future. Microbiol Mol Biol R. 2014;78(2):257\u201377. https:\/\/doi.org\/10.1128\/MMBR.00056-13.","journal-title":"Microbiol Mol Biol R"},{"key":"12180_CR20","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1089\/mdr.2006.12.192","volume":"12","author":"M Archambault","year":"2006","unstructured":"Archambault M, Petrov P, Hendriksen RS, Asseva G, Bangtrakulnonth A, Hasman H, Aarestrup FM. Molecular characterization and occurrence of extended-spectrum \u03b2-lactamase resistance genes among Salmonella enterica serovar Corvallis from Thailand, Bulgaria, and Denmark. MICROB Drug Resist. 2006;12:192\u201398. https:\/\/doi.org\/10.1089\/mdr.2006.12.19210.1089\/mdr.2006.12.192.","journal-title":"MICROB Drug Resist"},{"key":"12180_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2147\/IDR.S78876","volume":"8","author":"KO Akinyemi","year":"2015","unstructured":"Akinyemi KO, Iwalokun BA, Oyefolu BO, Fakorede CO. blaCTX-M-1 group extended spectrum beta-lactamase producing Salmonella Typhi from hospitalized patients in Lagos, Nigeria. Infect Drug Resist. 2015;8:99\u2013106. https:\/\/doi.org\/10.2147\/IDR.S78876.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"12180_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12879-023-08219-7","volume":"23","author":"DF Hlashwayo","year":"2023","unstructured":"Hlashwayo DF, Noormahomed EV, Bahule L, Benson CA, Schooley RT, Siga\u00faque B, Barrett KE, Bila CG. Susceptibility antibiotic screening reveals high rates of multidrug resistance of Salmonella, Shigella and Campylobacter in hiv infected and uninfected patients from Mozambique. BMC Infect Dis. 2023;23(1):255. https:\/\/doi.org\/10.1186\/s12879-023-08219-7.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"12180_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.puhe.2004.04.009","volume":"119","author":"KO Akinyemi","year":"2005","unstructured":"Akinyemi KO, Smith SI, Bola Oyefolu AO, Coker AO. Multidrug resistance in Salmonella enterica serovar Typhi isolated from patients with typhoid fever complications in Lagos, Nigeria. Public Health. 2005;119(4):321\u201327. https:\/\/doi.org\/10.1016\/j.puhe.2004.04.009.","journal-title":"Public Health"},{"key":"12180_CR24","doi-asserted-by":"publisher","first-page":"834048","DOI":"10.3389\/fitd.2022.834048","volume":"3","author":"AB Karikari","year":"2022","unstructured":"Karikari AB, Kpordze SW, Yamik DY, Saba CKS. Ready-to-eat food as sources of extended-spectrum \u03b2-lactamase-producing Salmonella and E. coli in tamale, Ghana. Front Trop Dis. 2022;3:834048. https:\/\/doi.org\/10.3389\/fitd.2022.834048.","journal-title":"Front Trop Dis"},{"issue":"12","key":"12180_CR25","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.4315\/JFP-20-172","volume":"83","author":"MS Parvin","year":"2020","unstructured":"Parvin MS, Hasan MM, Ali MY, Chowdhury EH, Rahman MT, Islam MT. Prevalence and multidrug resistance pattern of Salmonella carrying extended-spectrum \u03b2-lactamase in frozen chicken meat in Bangladesh. J Food Protect. 2020;83(12):2107\u201321. https:\/\/doi.org\/10.4315\/JFP-20-172.","journal-title":"J Food Protect"},{"issue":"3","key":"12180_CR26","first-page":"351","volume":"25","author":"KO Akinyemi","year":"2007","unstructured":"Akinyemi KO, Bamiro BS, Coker AO. Salmonellosis in Lagos, Nigeria: incidence of Plasmodium falciparum-associated co-infection, patterns of antimicrobial resistance, and emergence of reduced susceptibility to fluoroquinolones. J Health Popul Nutr. 2007;25(3):351\u201358. PMCID: PMC2754035 PMID: 18330069.","journal-title":"J Health Popul Nutr"},{"issue":"1","key":"12180_CR27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12879-025-10478-5","volume":"25","author":"J Nazir","year":"2025","unstructured":"Nazir J, Manzoor T, Saleem A, Gani U, Bhat SS, Khan S, Haq Z, Jha P, Ahmad SM. Combatting Salmonella: a focus on antimicrobial resistance and the need for effective vaccination. BMC Infect Dis. 2025;25(1):84. https:\/\/doi.org\/10.1186\/s12879-025-10478-5.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"12180_CR28","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1186\/s12879-019-4522-1","volume":"19","author":"G Acheampong","year":"2019","unstructured":"Acheampong G, Owusu M, Owusu-Ofori A, Osei I, Sarpong N, Sylverken A, Kung H-J, Cho S-T, Kuo C-H, Park SE, Marks F, Adu-Sarkodie Y, Owusu-Dabo E. Chromosomal and plasmid-mediated fluoroquinolone resistance in human Salmonella enterica infection in Ghana. BMC Infect Dis. 2019;19(1):898. https:\/\/doi.org\/10.1186\/s12879-019-4522-1.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"12180_CR29","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1128\/AAC.01400-08","volume":"53","author":"M Wang","year":"2009","unstructured":"Wang M, Guo Q, Xu X, Wang X, Ye X, Wu S, Shen J. New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis in China. Antimicrob Agents Chemother. 2009;53(5):1892\u201397. https:\/\/doi.org\/10.1128\/AAC.01400-08.","journal-title":"Antimicrob Agents Chemother"},{"key":"12180_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fmicb.2012.00024","volume":"3","author":"L Poirel","year":"2012","unstructured":"Poirel L, Cattoir V, Nordmann P. Plasmid-mediated quinolone resistance; interactions between human, animal, and environmental ecologies. Front Microbiol. 2012;3:24. https:\/\/doi.org\/10.3389\/fmicb.2012.00024.","journal-title":"Front Microbiol"},{"issue":"Suppl 1","key":"12180_CR31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1469-0691.2007.01855.x","volume":"14","author":"PM Hawkey","year":"2008","unstructured":"Hawkey PM. Prevalence and clonality of extended-spectrum \u03b2-lactamases in Asia. Clin Microbiol And Infect. 2008;14(Suppl 1):159\u201365. https:\/\/doi.org\/10.1111\/j.1469-0691.2007.01855.x.","journal-title":"Clin Microbiol And Infect"},{"issue":"Suppl 4","key":"12180_CR32","doi-asserted-by":"publisher","first-page":"S317","DOI":"10.1093\/cid\/civ711","volume":"61","author":"S Kariuki","year":"2015","unstructured":"Kariuki S, Onsare RS. Epidemiology and genomics of invasive nontyphoidal Salmonella infections in Kenya. Clin Infect Dis. 2015;61(Suppl 4):S317\u201324. https:\/\/doi.org\/10.1093\/cid\/civ711.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"12180_CR33","doi-asserted-by":"publisher","first-page":"027","DOI":"10.29328\/journal.abb.1001041","volume":"8","author":"R Richard","year":"2024","unstructured":"Richard R, N ETI, A NC, E MN. Antibacterial resistance and extended spectrum-beta lactamase (ESBL) phenotypes in enterobacteriaceae isolated from fecal samples of humans and animals in selected local government areas of Nasarawa State, Nigeria. Arch Biotechnol Biomed. 2024;8(1):027\u2013033.","journal-title":"Arch Biotechnol Biomed"},{"issue":"4","key":"12180_CR34","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1556\/030.66.2019.034","volume":"66","author":"A Ajayi","year":"2019","unstructured":"Ajayi A, Smith SI, Kalpy JC, Bode-Sojobi IO, Ren\u00e9 YK, Adeleye AI. Molecular diversity and antibiotic resistance gene profile of Salmonella enterica serovars isolated from humans and food animals in Lagos, Nigeria. Acta Microbiologica et Immunologica Hung. 2019;66(4):509\u201327. https:\/\/doi.org\/10.1556\/030.66.2019.034.","journal-title":"Acta Microbiologica et Immunologica Hung"},{"key":"12180_CR35","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1186\/s13104-016-2312-7","volume":"9","author":"M Ejo","year":"2016","unstructured":"Ejo M, Garedew L, Alebachew Z, Worku W. Prevalence and antimicrobial resistance of Salmonella isolated from animal-origin food items in Gondar, Ethiopia. BMC Res Notes. 2016;9:509. https:\/\/doi.org\/10.1186\/s13104-016-2312-7.","journal-title":"BMC Res Notes"},{"issue":"1","key":"12180_CR36","doi-asserted-by":"publisher","first-page":"e0296971","DOI":"10.1371\/journal.pone.0296971","volume":"19","author":"MK Aworh","year":"2024","unstructured":"Aworh MK, Nilsson P, Egyir B, Owusu FA, Hendriksen RS. Rare serovars of non-typhoidal Salmonella enterica isolated from humans, beef cattle and abattoir environments in Nigeria. PLoS One. 2024;19(1):e0296971. https:\/\/doi.org\/10.1371\/journal.pone.0296971.","journal-title":"PLoS One"},{"key":"12180_CR37","doi-asserted-by":"publisher","unstructured":"Punchihewage-Don AJ, Schwarz J, Diria A, Bowers J, Parveen S. Prevalence and antibiotic resistance of Salmonella in organic and non-organic chickens on the Eastern Shore of Maryland, usa. Front Microbiol. 2024;14. https:\/\/doi.org\/10.3389\/fmicb.2023.1272892.","DOI":"10.3389\/fmicb.2023.1272892"},{"issue":"7","key":"12180_CR38","first-page":"119","volume":"2","author":"IR Iroha","year":"2016","unstructured":"Iroha IR, Aniokette U, Iroha SC, Ajah M, Nwakaeze AE. Occurrence of multi-drug-resistant gram-negative bacteria from poultry and poultry products sold in Abakaliki. J Retailing Agric Sci Food Technol. 2016;2(7):119\u201324.","journal-title":"J Retailing Agric Sci Food Technol"},{"issue":"3 Suppl","key":"12180_CR39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4269\/ajtmh.18-0045","volume":"99","author":"KO Akinyemi","year":"2018","unstructured":"Akinyemi KO, Oyefolu AOB, Mutiu BW, Iwalokun AB, Ayeni SE, Ajose SO, Obaro SK. Typhoid fever: tracking the trend in Nigeria. The Am J Trop Med And Hyg. 2018;99(3 Suppl):41\u201347. https:\/\/doi.org\/10.4269\/ajtmh.18-0045.","journal-title":"The Am J Trop Med And Hyg"},{"key":"12180_CR40","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12866-023-02901-1","volume":"23","author":"KO Akinyemi","year":"2023","unstructured":"Akinyemi KO, Fakorede CO, Linde J, Methner U, Wareth G, Tomaso H, Neubauer H. Whole genome sequencing of Salmonella enterica serovars isolated from humans, animals, and the environment in Lagos, Nigeria. BMC Microbiol. 2023;23:164. https:\/\/doi.org\/10.1186\/s12866-023-02901-1.","journal-title":"BMC Microbiol"},{"issue":"6","key":"12180_CR41","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.3390\/microorganisms13061174","volume":"13","author":"VO Adetunji","year":"2025","unstructured":"Adetunji VO, Davies A, Chisnall T, Ndahi MD, Fagbamila IO, Ekeng E, Adebiyi I, Falodun OI, Card RM. Genomic diversity and antibiotic resistance of Escherichia coli and Salmonella from poultry farms in Oyo State, Nigeria. Microorganisms. 2025;13(6):1174. https:\/\/doi.org\/10.3390\/microorganisms13061174.","journal-title":"Microorganisms"},{"issue":"3","key":"12180_CR42","doi-asserted-by":"publisher","first-page":"165","DOI":"10.24875\/RIC.22000078","volume":"74","author":"KO Akinyemi","year":"2022","unstructured":"Akinyemi KO, Al-Khafaji NSK, F.T A-A, Fakorede CO, Al-Dahmoshi HOM, Iwalokun BA, Akpabio I, Alkafaas SS, Saki M. Extended-spectrum Beta-lactamases encoding genes among salmonella enterica serovar typhi isolates in patients with typhoid fever from four Academic medical centers in Lagos. Rev Invest Clin. 2022;74(3):165\u201371. https:\/\/doi.org\/10.24875\/RIC.22000078.","journal-title":"Rev Invest Clin"},{"key":"12180_CR43","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511543470","volume-title":"District laboratory practice in tropical countries","author":"M Cheesbrough","year":"2006","unstructured":"Cheesbrough M. District laboratory practice in tropical countries. 2nd ed., Part 2). Cambridge University Press; 2006. https:\/\/doi.org\/10.1017\/CBO9780511543470.","edition":"2nd"},{"key":"12180_CR44","first-page":"53","volume-title":"Manual for the laboratory identification and antimicrobial susceptibility testing of bacterial pathogens of public health importance","author":"World Health Organization (WHO)","year":"2010","unstructured":"World Health Organization (WHO). Laboratory protocols: isolation of salmonella spp. In: Manual for the laboratory identification and antimicrobial susceptibility testing of bacterial pathogens of public health importance. WHO Press; 2010. p. 53\u201371."},{"key":"12180_CR45","volume-title":"CLSI supplement M100","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2020","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. In: CLSI supplement M100. 30th. Clinical and Laboratory Standards Institute; 2020.","edition":"30th"},{"key":"12180_CR46","unstructured":"International Organization for Standardization. Microbiology of the food chain - horizontal method for the detection, enumeration and serotyping of salmonella - part, 3: guidelines for serotyping of salmonella spp. ISO; 2014. 2014. p. ISO\/TR 6579\u20133."},{"key":"12180_CR47","volume-title":"CLSI supplement M100","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2021","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. In: CLSI supplement M100. 31st. Wayne, PA: Clinical and Laboratory Standards Institute; 2021.","edition":"31st"},{"issue":"4","key":"12180_CR48","first-page":"565","volume":"84","author":"PC Ejikeugwu","year":"2012","unstructured":"Ejikeugwu PC, Nkechukwu MI, Ugwu CM, Iroha IR, Esimone CO. Extended - spectrum \u03b2 - lactamase - producing Escherichia coli isolates from suspected community acquired urinary tract infections. Eur J Criminol Sci Res. 2012;84(4):565\u201371.","journal-title":"Eur J Criminol Sci Res"},{"issue":"6","key":"12180_CR49","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.13040\/IJPSR.0975-8232.14(6).3063-69","volume":"14","author":"CS Iroha","year":"2023","unstructured":"Iroha CS, Ugwu MC, Esimone CO, Iroha IR, Ibiam FA, Ejikeugwu PC. Molecular characterization of ESBL and Colistin resistance genes among clinical isolates of gram- negative bacteria in a tertiary hospital in Abakaliki, Nigeria. Int J Pharm Sci Res. 2023;14(6):3063. https:\/\/doi.org\/10.13040\/IJPSR.0975-8232.14(6).3063-69.","journal-title":"Int J Pharm Sci Res"},{"key":"12180_CR50","volume-title":"ZymoBIOMICS\u2122 dna miniprep kit instruction manual, ver. 1.5.4","author":"Zymo Research","year":"2023","unstructured":"Zymo Research. ZymoBIOMICS\u2122 dna miniprep kit instruction manual, ver. 1.5.4. Zymo Research Corporation; 2023. https:\/\/files.zymoresearch.com\/protocols\/_d4300t_d4300_d4304_zymobiomics_dna_miniprep_kit.pdf."},{"issue":"2","key":"12180_CR51","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0378-1097(03)00306-9","volume":"223","author":"K Colom","year":"2003","unstructured":"Colom K, P\u00e9rez J, Alonso R, Fern\u00e1ndez-Aranguiz A, Lari\u00f1o E, Cisterna R. Simple and reliable multiplex pcr assay for detection of bla_tem, bla_shv and bla_OXA-1 genes in enterobacteriaceae. FEMS Microbiol Lett. 2003;223(2):147\u201351.","journal-title":"FEMS Microbiol Lett"},{"key":"12180_CR52","doi-asserted-by":"publisher","first-page":"e01863","DOI":"10.1016\/j.sciaf.2023.e01863","volume":"21","author":"E Egwu","year":"2023","unstructured":"Egwu E, Ibiam FA, Moses IB, Iroha CS, Orji I, Okafor-Alu FN, Eze CO, Iroha IR. Antimicrobial susceptibility and molecular characteristics of \u03b2-lactam- and fluoroquinolone-resistant Escherichia coli from human clinical samples in Nigeria. Sci Afr. 2023;21:e01863. https:\/\/doi.org\/10.1016\/j.sciaf.2023.e01863.","journal-title":"Sci Afr"},{"issue":"4","key":"12180_CR53","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1006\/mcpr.2001.0363","volume":"15","author":"LK Ng","year":"2001","unstructured":"Ng LK, Martin I, Alfa M, Mulvey M. Multiplex pcr for the detection of tetracycline resistant genes. Mol And Cellular Probes. 2001;15(4):209\u201315. https:\/\/doi.org\/10.1006\/mcpr.2001.0363.","journal-title":"Mol And Cellular Probes"},{"issue":"12","key":"12180_CR54","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1016\/j.watres.2006.04.017","volume":"40","author":"R Pei","year":"2006","unstructured":"Pei R, Kim SC, Carlson KH, Pruden A. Effect of river landscape on the sediment concentrations of antibiotics and corresponding antibiotic resistance genes (arg). Water Res. 2006;40(12):2427\u201335. https:\/\/doi.org\/10.1016\/j.watres.2006.04.017.","journal-title":"Water Res"},{"issue":"2","key":"12180_CR55","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/jac\/dkm204","volume":"60","author":"V Cattoir","year":"2007","unstructured":"Cattoir V, Poirel L, Rotimi V, Soussy CJ, Nordmann P. Multiplex pcr for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. The J Antimicrob Chemother. 2007;60(2):394\u201397. https:\/\/doi.org\/10.1093\/jac\/dkm204.","journal-title":"The J Antimicrob Chemother"},{"issue":"3","key":"12180_CR56","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol And Infect. 2012;18(3):268\u201381. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x.","journal-title":"Clin Microbiol And Infect"},{"key":"12180_CR57","volume-title":"CLSI supplement M100","author":"Clinical and Laboratory Standards Institute","year":"2023","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. In: CLSI supplement M100. 33rd. CLSI; 2023.","edition":"33rd"},{"key":"12180_CR58","volume-title":"2021 demographic statistics bulletin","author":"National Bureau of Statistics (NBS)","year":"2021","unstructured":"National Bureau of Statistics (NBS). 2021 demographic statistics bulletin. Abuja: NBS Nigeria; 2021."},{"issue":"4","key":"12180_CR59","doi-asserted-by":"publisher","first-page":"e008719","DOI":"10.1136\/bmjgh-2022-008719","volume":"7","author":"AC Ezeh","year":"2022","unstructured":"Ezeh AC, Banke-Thomas A, Fagbamigbe AF, et al. Sex disparities in health service utilization and outcomes in sub-saharan Africa: a systematic review. BMJ Global Health. 2022;7(4):e008719. https:\/\/doi.org\/10.1136\/bmjgh-2022-008719.","journal-title":"BMJ Global Health"},{"issue":"7","key":"12180_CR60","first-page":"1049","volume":"5","author":"A Goel","year":"2024","unstructured":"Goel A, Goel P. Barriers to healthcare access in low-income countries and marginalized communities. Int J Multiling Res Publ And Rev. 2024;5(7):1049\u201354. https:\/\/www.ijrpr.com.","journal-title":"Int J Multiling Res Publ And Rev"},{"key":"12180_CR61","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1186\/s12913-025-12761-2","volume":"25","author":"H Aragie","year":"2025","unstructured":"Aragie H, Negash HK, Getnet M, Tesfaye W, Gela YY, Asefa T, Woldeyes MM, Endale HT. Barriers to healthcare access: a multilevel analysis of individual- and community-level factors affecting female youths\u2019 access to healthcare services in Senegal. BMC Health Serv Res. 2025;25:607.","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"12180_CR62","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1136\/ejhpharm-2021-002762","volume":"29","author":"CO Iheanacho","year":"2022","unstructured":"Iheanacho CO, Eze UIH. Antimicrobial resistance in Nigeria: challenges and charting the way forward. Eur J Hosp Pharm. 2022;29(2):119. https:\/\/doi.org\/10.1136\/ejhpharm-2021-002762.","journal-title":"Eur J Hosp Pharm"},{"key":"12180_CR63","unstructured":"World Health Organization (WHO). Global antimicrobial resistance and use surveillance system (glass) report 2023. 2023. Geneva: WHO."},{"issue":"12","key":"12180_CR64","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1371\/journal.pone.0051823","volume":"7","author":"K Thriemer","year":"2012","unstructured":"Thriemer K, Ley BB, Ame SS, Deen JL, de Pak G, Chang NY, Hashim R, Schmied WH, Busch C-L, Nixon S, Morrissey A, Puri MK, Ochiai RL, Wierzba T, Clemens JD, Ali M, Jiddawi MS, von Seidlein L, Ali SM. Clinical and epidemiological features of typhoid fever in Pemba, Zanzibar: assessment of the performance of the who case definitions. PLoS One. 2012;7(12):518.","journal-title":"PLoS One"},{"key":"12180_CR65","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1542\/peds.2012-1181","volume":"131","author":"C Gillio-Meina","year":"2013","unstructured":"Gillio-Meina C, Cepinskas G, Cecchini EL, Fraser DD. Translational research in pediatrics ii: blood collection, processing, shipping, and storage. Pediatrics. 2013;131:754\u201366.","journal-title":"Pediatrics"},{"key":"12180_CR66","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12941-016-0147-z","volume":"15","author":"V Mogasale","year":"2016","unstructured":"Mogasale V, Ramani E, Mogasale VV, Park JY. What proportion of Salmonella Typhi cases are detected by blood culture? A systematic literature review. Ann Of Clin Microbiol And Antimicrobials. 2016;15:32. https:\/\/doi.org\/10.1186\/s12941-016-0147-z.","journal-title":"Ann Of Clin Microbiol And Antimicrobials"},{"key":"12180_CR67","doi-asserted-by":"publisher","first-page":"e0005118","DOI":"10.1371\/journal.pntd.0005118","volume":"11","author":"IV Uche","year":"2017","unstructured":"Uche IV, MacLennan CA, Saul A. A systematic review of the incidence, risk factors and case fatality rates of invasive nontyphoidal salmonella (iNTS) disease in Africa (1966 to 2014). PLoS Negl Trop Dis. 2017;11:e0005118.","journal-title":"PLoS Negl Trop Dis"},{"key":"12180_CR68","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12916-020-01652-4","volume":"18","author":"B Tack","year":"2020","unstructured":"Tack B, Vanaenrode J, Verbakel JY, Toelen J, Jacobs J. Invasive non-typhoidal Salmonella infections in sub-saharan Africa: a systematic review on antimicrobial resistance and treatment. BMC Med. 2020;18:212.","journal-title":"BMC Med"},{"issue":"9835","key":"12180_CR69","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1016\/S0140-6736(11)61752-2","volume":"379","author":"NA Feasey","year":"2012","unstructured":"Feasey NA, Dougan G, Kingsley RA, Heyderman RS, Gordon MA. Invasive non-typhoidal Salmonella disease: an emerging and neglected tropical disease in Africa. Lancet. 2012;379(9835):2489\u201399. https:\/\/doi.org\/10.1016\/S0140-6736(11)61752-2.","journal-title":"Lancet"},{"issue":"9","key":"12180_CR70","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/infdis\/jiv598","volume":"213","author":"FJ Fuche","year":"2016","unstructured":"Fuche FJ, Sen S, Jones JA, Nkeze J, Permala-Booth J, Tapia MD, Sow SO, Tamboura B, Tour\u00e9 A, Onwuchekwa U, Sylla M, Kotloff KL, Tennant SM. Characterization of invasive salmonella serogroup C1 infections in Mali. The J Infect Dis. 2016;213(9):1489\u201394. https:\/\/doi.org\/10.1093\/infdis\/jiv598.","journal-title":"The J Infect Dis"},{"issue":"6","key":"12180_CR71","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3201\/eid2106.140999","volume":"21","author":"TT Ao","year":"2015","unstructured":"Ao TT, Feasey NA, Gordon MA, Keddy KH, Angulo FJ, Crump JA. Global burden of invasive nontyphoidal Salmonella disease, 2010. Emerg. Infect. Dis. 2015;21(6):941\u201349. https:\/\/doi.org\/10.3201\/eid2106.140999.","journal-title":"Emerg. Infect. Dis"},{"issue":"8","key":"12180_CR72","doi-asserted-by":"publisher","first-page":"e0010716","DOI":"10.1371\/journal.pntd.0010716","volume":"16","author":"OO Ikhimiukor","year":"2022","unstructured":"Ikhimiukor OO, Oaikhena AO, Afolayan AO, Fadeyi A, Kehinde A, Ogunleye VO, \u2026 & Okeke IN. Genomic characterization of invasive typhoidal and non-typhoidal Salmonella in southwestern Nigeria. PLoS Negl Trop Dis. 2022;16(8):e0010716. https:\/\/doi.org\/10.1371\/journal.pntd.0010716.","journal-title":"PLoS Negl Trop Dis"},{"key":"12180_CR73","doi-asserted-by":"publisher","first-page":"205031212311753","DOI":"10.1177\/20503121231175322","volume":"11","author":"LI Uzairne","year":"2023","unstructured":"Uzairne LI, Shittu OB, Ojo OE, Obuotor TM, Olanipekun G, Ajose T, Arogbonlo R, Medugu N, Ebruke B, Obaro SK. Antimicrobial resistance and virulence genes of invasive salmonella enterica from children with bacteremia in north- central, Nigeria. Sage Open Med. 2023;11:20503121231175322.","journal-title":"Sage Open Med"},{"key":"12180_CR74","doi-asserted-by":"publisher","first-page":"1524287","DOI":"10.3389\/fmicb.2025.1524287","volume":"16","author":"G Kumar","year":"2025","unstructured":"Kumar G, Kumar S, Jangid H, Dutta J, Shidiki A. The rise of non-typhoidal Salmonella: an emerging global public health concern. Front Microbiol. 2025;16:1524287. https:\/\/doi.org\/10.3389\/fmicb.2025.1524287.","journal-title":"Front Microbiol"},{"key":"12180_CR75","doi-asserted-by":"publisher","first-page":"822802","DOI":"10.3389\/fmicb.2021.822802","volume":"12","author":"YY Liu","year":"2021","unstructured":"Liu YY, Chen S, Burrus V, Liu JH. Editorial: globally or regionally spread of epidemic plasmids carrying clinically important resistance genes: epidemiology, molecular mechanism, and drivers. Front Microbiol. 2021;12:822802. https:\/\/doi.org\/10.3389\/fmicb.2021.822802.","journal-title":"Front Microbiol"},{"issue":"4","key":"12180_CR76","doi-asserted-by":"publisher","first-page":"298","DOI":"10.4314\/gmj.v55i4.11","volume":"55","author":"JG Deku","year":"2021","unstructured":"Deku JG, Duedu KO, Ativi E, Kpene GE, Feglo PK. Occurrence and distribution of extended-spectrum \u03b2-lactamase in clinical Escherichia coli isolates at Ho Teaching Hospital in Ghana. Ghana Med J. 2021;55(4):298\u2013307. https:\/\/doi.org\/10.4314\/gmj.v55i4.11.","journal-title":"Ghana Med J"},{"key":"12180_CR77","doi-asserted-by":"publisher","unstructured":"Omulo S, Oluka M, Achieng L, Osoro E, Kinuthia R, Guantai A, Opanga SA, Ongayo M, Ndegwa L, Verani JR, Wesangula E, Nyakiba J, Makori J, Sugut W, Kwobah C, Osuka H, Njenga MK, Call DR, Palmer GH, VanderEnde D, Luvsansharav UL. Point-prevalence survey of antibiotic use at three public referral hospitals in Kenya. PLoS One. 2022;17(6), Article e0270048. https:\/\/doi.org\/10.1371\/journal.pone.0270048.","DOI":"10.1371\/journal.pone.0270048"},{"key":"12180_CR78","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2020.37.213.24988","author":"MH Dirar","year":"2020","unstructured":"Dirar MH, Bilal NE, Ibrahim ME, Hamid ME. Prevalence of extended-spectrum \u03b2-lactamase (ESBL) and molecular detection of blaTEM, blaSHV and blaCTX-M genotypes among Enterobacteriaceae isolates from patients in Khartoum, Sudan. Pan Afr Med. 2020. https:\/\/doi.org\/10.11604\/pamj.2020.37.213.24988.","journal-title":"Pan Afr Med"},{"issue":"4","key":"12180_CR79","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.bjid.2013.10.005","volume":"18","author":"M Guzm\u00e1n-Blanco","year":"2014","unstructured":"Guzm\u00e1n-Blanco M, Labarca JA, Villegas MV, Gotuzzo E. Extended spectrum \u03b2-lactamase producers among nosocomial Enterobacteriaceae in Latin America. Braz J Infect Dis. 2014;18(4):421\u201333. https:\/\/doi.org\/10.1016\/j.bjid.2013.10.005.","journal-title":"Braz J Infect Dis"},{"issue":"4","key":"12180_CR80","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1128\/CMR.00016-09","volume":"22","author":"J Strahilevitz","year":"2009","unstructured":"Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev. 2009;22(4):664\u201389. https:\/\/doi.org\/10.1128\/CMR.00016-09.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"12180_CR81","doi-asserted-by":"publisher","first-page":"dlae127","DOI":"10.1093\/jacamr\/dlae127","volume":"6","author":"L Kherroubi","year":"2024","unstructured":"Kherroubi L, Bacon J, Rahman KM. Navigating fluoroquinolone resistance in gram-negative bacteria: a comprehensive evaluation. JAC Antimicrob Resist. 2024;6(4):dlae127. https:\/\/doi.org\/10.1093\/jacamr\/dlae127.","journal-title":"JAC Antimicrob Resist"},{"key":"12180_CR82","doi-asserted-by":"publisher","first-page":"e110","DOI":"10.1017\/S0950268822000814","volume":"150","author":"J Puangseree","year":"2022","unstructured":"Puangseree J, Prathan R, Srisanga S, Angkittitrakul S, Chuanchuen R. Plasmid profile analysis of Escherichia coli and Salmonella enterica isolated from pigs, pork, and humans. Epidemiol Infect. 2022;150:e110. https:\/\/doi.org\/10.1017\/S0950268822000814.","journal-title":"Epidemiol Infect"},{"key":"12180_CR83","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.drup.2016.09.001","volume":"29","author":"JM Rodriguez-Martinez","year":"2016","unstructured":"Rodriguez-Martinez JM, Machuca J, Cano ME, Calvo J, Martinez-Martinez L, Pascual A. Plasmid-mediated quinolone resistance: two decades on. Drug Resist Updates. 2016;29:13\u201329. https:\/\/doi.org\/10.1016\/j.drup.2016.09.001.","journal-title":"Drug Resist Updates"},{"issue":"Suppl_3","key":"12180_CR84","doi-asserted-by":"publisher","first-page":"S303","DOI":"10.1093\/cid\/ciaa1313","volume":"71","author":"JR Andrews","year":"2020","unstructured":"Andrews JR, Vaidya K, Saha S, Qamar FN, Abedin J, Karkey A, Ahsan K, Rahman S, Baidya S, Saha SK, Baker S, Ochiai RL. Antibiotic use prior to hospital presentation among individuals with suspected enteric fever in Nepal, Bangladesh, and Pakistan. Clin Infect Dis. 2020;71(Suppl_3):S303\u2013S310. https:\/\/doi.org\/10.1093\/cid\/ciaa1313.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"12180_CR85","doi-asserted-by":"publisher","first-page":"e000195","DOI":"10.1099\/mgen.0.000195","volume":"4","author":"WL Cuypers","year":"2018","unstructured":"Cuypers WL, Jacobs J, Wong V, Klemm EJ, Deborggraeve S, Van Puyvelde S. Fluoroquinolone resistance in Salmonella: insights by whole-genome sequencing. Microb. Genomics. 2018;4(7):e000195. https:\/\/doi.org\/10.1099\/mgen.0.000195.","journal-title":"Microb. Genomics"},{"issue":"8","key":"12180_CR86","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3390\/diagnostics15081044","volume":"15","author":"F Serapide","year":"2025","unstructured":"Serapide F, Pallone R, Quirino A, Marascio N, Barreca GS, Davoli C, Lionello R, Matera G, Russo A. Impact of multiplex pcr on diagnosis of bacterial and fungal infections and choice of appropriate antimicrobial therapy. Diagnostics. 2025;15(8):1044. https:\/\/doi.org\/10.3390\/diagnostics15081044.","journal-title":"Diagnostics"},{"issue":"4","key":"12180_CR87","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/antibiotics14040363","volume":"14","author":"FJ Chamizo-L\u00f3pez","year":"2025","unstructured":"Chamizo-L\u00f3pez FJ, Guti\u00e9rrez-Fern\u00e1ndez J, Rojo-Mart\u00edn MD, Borrego-Alcaide AB, Gonz\u00e1lez-Hevilla A, Lara-Oya A, Palop-Borr\u00e1s B, Navarro-Mar\u00ed JM, P\u00e9rez-Ruiz M. Development and validation of a multiplex real-time pcr assay for rapid screening of main carbapenemase genes in clinical isolates and surveillance samples. Antibiotics. 2025;14(4):363. https:\/\/doi.org\/10.3390\/antibiotics14040363.","journal-title":"Antibiotics"},{"key":"12180_CR88","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s41182-017-0043-z","volume":"45","author":"LA Andoh","year":"2017","unstructured":"Andoh LA, Ahmed S, Olsen JE, Obiri-Danso K, Newman MJ, Opintan JA, Barco L, Dalsgaard A. Prevalence and characterization of Salmonella among humans in Ghana. Trop Med Health. 2017;45:3. https:\/\/doi.org\/10.1186\/s41182-017-0043-z.","journal-title":"Trop Med Health"},{"key":"12180_CR89","doi-asserted-by":"publisher","first-page":"100448","DOI":"10.1016\/j.ijmmb.2023.100448","volume":"46","author":"S Dahiya","year":"2023","unstructured":"Dahiya S, Katiyar A, Rai S, Sharma P, Kaur P, Kapil A. Ceftriaxone-resistant Salmonella Typhi isolated from paediatric patients in north India: insights into genetic profiles and antibiotic resistance mechanisms. Indian J Med Microbiol. 2023;46:100448.","journal-title":"Indian J Med Microbiol"},{"key":"12180_CR90","doi-asserted-by":"publisher","first-page":"1496716","DOI":"10.3389\/fmicb.2025.1496716","volume":"16","author":"S Zhang","year":"2025","unstructured":"Zhang S, Yang J, Abbas M, Yang Q, Li Q, Liu M, Zhu D, Wang M, Tian B, Cheng A. Threats across boundaries: the spread of ESBL-positive Enterobacteriaceae bacteria and its challenge to the \u201cone health\u201d concept. Front Microbiol. 2025;16:1496716. https:\/\/doi.org\/10.3389\/fmicb.2025.1496716.","journal-title":"Front Microbiol"},{"issue":"3","key":"12180_CR91","doi-asserted-by":"publisher","first-page":"743","DOI":"10.14202\/vetworld.2022.743-749","volume":"15","author":"ME Velazquez-Meza","year":"2022","unstructured":"Velazquez-Meza ME, Galarde-L\u00f3pez M, Carrillo-Quir\u00f3z B, Alpuche-Aranda CM. Antimicrobial resistance: one health approach. Vet World. 2022;15(3):743\u201349. https:\/\/doi.org\/10.14202\/vetworld.2022.743-749.","journal-title":"Vet World"},{"key":"12180_CR92","doi-asserted-by":"publisher","unstructured":"Albur MS, Noel A, Bowker K, MacGowan A. The combination of colistin and fosfomycin is synergistic against NDM-1-producing Enterobacteriaceae in in vitro pharmacokinetic\/pharmacodynamic model experiments. Int. J. Antimicrob. Agents. 2015;46(5):560\u201367. https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.07.019.","DOI":"10.1016\/j.ijantimicag.2015.07.019"},{"key":"12180_CR93","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fcimb.2017.00246","volume":"7","author":"W Yu","year":"2017","unstructured":"Yu W, Zhou K, Guo L, Ji J, Niu T, Xiao T, Shen P, Xiao Y. In vitro pharmacokinetics\/pharmacodynamics evaluation of fosfomycin combined with amikacin or colistin against KPC2-producing Klebsiella pneumoniae. Front Cell Infect Microbiol. 2017;7:246. https:\/\/doi.org\/10.3389\/fcimb.2017.00246.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"12180_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/6634684","volume":"2021","author":"M Qadi","year":"2021","unstructured":"Qadi M, Alhato S, Khayyat R, Elmanama AA. Colistin resistance among Enterobacteriaceae isolated from clinical samples in Gaza Strip. Can J Infect Dis Med Microbiol. 2021;2021(2):1\u20136. https:\/\/doi.org\/10.1155\/2021\/6634684.","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"12180_CR95","doi-asserted-by":"publisher","first-page":"6203","DOI":"10.2147\/IDR.S385411","volume":"15","author":"R Shrief","year":"2022","unstructured":"Shrief R, El-Ashry AH, Mahmoud R, El-Mahdy R. Effect of colistin, fosfomycin and meropenem\/vaborbactam on carbapenem-resistant Enterobacterales in Egypt: a cross-sectional study. J Infect And Drug Resist. 2022;15:6203\u201314. https:\/\/doi.org\/10.2147\/IDR.S385411.","journal-title":"J Infect And Drug Resist"},{"issue":"8","key":"12180_CR96","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1080\/02664763.2023.2208773","volume":"51","author":"D Jarqu\u00edn","year":"2023","unstructured":"Jarqu\u00edn D, Roy A, Clarke B, Ghosal S. Combining phenotypic and genomic data to improve prediction of binary traits. J Appl Stat. 2023;51(8):1497\u2013523. https:\/\/doi.org\/10.1080\/02664763.2023.2208773.","journal-title":"J Appl Stat"},{"key":"12180_CR97","doi-asserted-by":"publisher","unstructured":"Leung RKK, Wang Y, Ma RCW, Luk AOY, Lam V, Ng M, So WY, Tsui SKW, Chan JCN. Using a multi-staged strategy based on machine learning and mathematical modeling to predict genotype-phenotype risk patterns in diabetic kidney disease: a prospective case-control cohort analysis. BMC Nephrol. 2013;14, Article 162. https:\/\/doi.org\/10.1186\/1471-2369-14-162.","DOI":"10.1186\/1471-2369-14-162"},{"key":"12180_CR98","doi-asserted-by":"publisher","unstructured":"Fang S-B, Lauderdale T-LY, Huang C-H, Chang P-R, Wang Y-H, Shigemura K, Lin Y-H, Chang W-C, Wang K-C, Huang T-W, Chang Y-C. Genotypic diversity of ciprofloxacin nonsusceptibility and its relationship with minimum inhibitory concentrations in nontyphoidal Salmonella clinical isolates in Taiwan. Antibiotics. 2021), 1383;10(11). https:\/\/doi.org\/10.3390\/antibiotics10111383.","DOI":"10.3390\/antibiotics10111383"},{"key":"12180_CR99","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/1471-2334-11-255","volume":"11","author":"C Surcouf","year":"2011","unstructured":"Surcouf C, Heng S, Pierre-Audigier C, Cadet-Daniel V, Namouchi A, Murray A, Gicquel B, Guillard B. Molecular detection of fluoroquinolone-resistance in multi-drug resistant tuberculosis in Cambodia suggests low association with xdr phenotypes. BMC Infect Dis. 2011;11:255. https:\/\/doi.org\/10.1186\/1471-2334-11-255.","journal-title":"BMC Infect Dis"},{"key":"12180_CR100","doi-asserted-by":"publisher","first-page":"115953","DOI":"10.1016\/j.geoderma.2022.115953","volume":"422","author":"A Wadoux","year":"2022","unstructured":"Wadoux A, Molnar C. Beyond prediction: methods for interpreting complex models of soil variation. Geoderma. 2022;422:115953.","journal-title":"Geoderma"},{"key":"12180_CR101","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s44163-025-00436-0","volume":"5","author":"A Hassan","year":"2025","unstructured":"Hassan A, Hussein M, Mohamed F, Yusuf I. Exploring the application of machine learning and shap explanations to predict health facility deliveries in Somalia. Clin And Transl Sci. 2025;5:211. https:\/\/doi.org\/10.1007\/s44163-025-00436-0.","journal-title":"Clin And Transl Sci"},{"issue":"11","key":"12180_CR102","doi-asserted-by":"publisher","first-page":"e70056","DOI":"10.1111\/cts.70056","volume":"17","author":"AV Ponce-Bobadilla","year":"2024","unstructured":"Ponce-Bobadilla AV, Schmitt V, Maier CS, Mensing S, Stodtmann S. Practical guide to shap analysis: explaining supervised machine learning model predictions in drug development. Clin And Transl Sci. 2024;17(11):e70056. https:\/\/doi.org\/10.1111\/cts.70056.","journal-title":"Clin And Transl Sci"},{"issue":"3","key":"12180_CR103","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/antibiotics12030523","volume":"12","author":"T Ali","year":"2023","unstructured":"Ali T, Ahmed S, Aslam M. Artificial intelligence for antimicrobial resistance prediction: challenges and opportunities towards practical implementation. Antibiotics. 2023;12(3):523. https:\/\/doi.org\/10.3390\/antibiotics12030523.","journal-title":"Antibiotics"},{"key":"12180_CR104","doi-asserted-by":"publisher","first-page":"1160224","DOI":"10.3389\/fmicb.2023.1160224","volume":"14","author":"J Kim","year":"2023","unstructured":"Kim J, Rupasinghe R, Halev A, Huang C, Rezaei S, Clavijo MJ, Robbins RC, Mart\u00ednez-L\u00f3pez B, Liu X. Predicting antimicrobial resistance of bacterial pathogens using time series analysis. Front Microbiol. 2023;14:1160224. https:\/\/doi.org\/10.3389\/fmicb.2023.1160224.","journal-title":"Front Microbiol"},{"issue":"3","key":"12180_CR105","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3390\/antibiotics12030452","volume":"12","author":"A Sakagianni","year":"2023","unstructured":"Sakagianni A, Koufopoulou C, Feretzakis G, Kalles D, Verykios VS, Myrianthefs P, Fildisis G. Using machine learning to predict antimicrobial resistance\u2015A literature review. Antibiotics. 2023;12(3):452. https:\/\/doi.org\/10.3390\/antibiotics12030452.","journal-title":"Antibiotics"},{"issue":"5","key":"12180_CR106","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.bjid.2012.05.001","volume":"16","author":"P Mart\u00ednez","year":"2012","unstructured":"Mart\u00ednez P, Garz\u00f3n D, Mattar S. CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia. Braz J Infect Dis. 2012;16(5):420\u201325. https:\/\/doi.org\/10.1016\/j.bjid.2012.05.001.","journal-title":"Braz J Infect Dis"},{"key":"12180_CR107","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijid.2020.07.084","volume":"99","author":"M Maina","year":"2020","unstructured":"Maina M, et al. Antibiotic use in Kenyan public hospitals: prevalence, appropriateness and link to guideline availability. Int J Infect Dis. 2020;99:10\u201318.","journal-title":"Int J Infect Dis"},{"issue":"10","key":"12180_CR108","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4236\/aim.2021.1110041","volume":"11","author":"CW Wairimu","year":"2021","unstructured":"Wairimu CW, Odari EO, Makobe CK, Kariuki S. Antimicrobial susceptibility and genetic basis of resistance of Klebsiella spp. isolated from diarrheic and non-diarrheic children at health facilities in Mukuru informal settlement, Nairobi, Kenya. Adv Microbiol. 2021;11(10):445\u201360. https:\/\/doi.org\/10.4236\/aim.2021.1110041.","journal-title":"Adv Microbiol"},{"key":"12180_CR109","doi-asserted-by":"publisher","unstructured":"Abayneh M, Zeynudin A, Tamrat R, Tadesse M, Tamirat A. Drug resistance and extended-spectrum \u03b2-lactamase (ESBLs)-producing Enterobacteriaceae, Acinetobacter and Pseudomonas species from the views of one health approach in Ethiopia: a systematic review and meta-analysis. One Health Outlook. 2023;5, Article 12. https:\/\/doi.org\/10.1186\/s42522-023-00089-y.","DOI":"10.1186\/s42522-023-00089-y"},{"issue":"11","key":"12180_CR110","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.3390\/biomedicines11112937","volume":"11","author":"A Husna","year":"2023","unstructured":"Husna A, Rahman MM, Badruzzaman ATM, Sikder MH, Islam MR, Rahman MT, Alam J, Ashour HM. Extended-spectrum \u03b2-lactamases (ESBL): challenges and opportunities. Biomedicines. 2023;11(11):2937.","journal-title":"Biomedicines"},{"issue":"6","key":"12180_CR111","doi-asserted-by":"publisher","first-page":"e03956","DOI":"10.1128\/spectrum.03956-23","volume":"12","author":"BM Flatgard","year":"2024","unstructured":"Flatgard BM, Williams AD, Amin MB, Hobman JL, Stekel DJ, Rousham EK, Islam MA. Tracking antimicrobial resistance transmission in urban and rural communities in Bangladesh: a one health study of genomic diversity of ESBL-producing and carbapenem-resistant Escherichia coli. Microbiol Spectr. 2024;12(6):e03956\u201323. https:\/\/doi.org\/10.1128\/spectrum.03956-23.","journal-title":"Microbiol Spectr"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12180-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12180-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12180-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:03:46Z","timestamp":1781618626000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12180-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":111,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12180"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12180-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Alex Ekwueme Federal University Teaching Hospital, Abakaliki (AE-FUTHA) Ethics Committee via FETHA\/REC\/VOL 2\/2019\/232. Written informed consent was approved by the ethics committee and verbal informed consent was obtained from all patients, and data confidentiality was maintained per the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1833"}}